INTUITIVE SURGICAL INC (ISRG) Latest Filing Signal

Latest Filing: 10-K  |  Filed Feb 3, 2026

Cross-checked across multiple AI analysts and grounded in the latest SEC filing.

powered by: earningsVibe.ai

Question:
What is the latest filing signal for INTUITIVE SURGICAL INC?
Answer:
Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-K, INTUITIVE SURGICAL INC's filing signal continuing positive.
earningsVibe SuperAnalyst™ Verdict: CONTINUING POSITIVE

Signal Performance — Stock Price Since Filing

30-Day Change
+3.72%
from filing date
60-Day Change
-5.49%
from filing date

Underlying analyst views from Perplexity, Gemini, Claude, and ChatGPT

PERPLEXITY
Continuing Positive
GEMINI
Continuing Positive
CLAUDE
Continuing Positive
CHATGPT
Continuing Positive

Unlock the Full Filing Analysis

See full earningsSig™ and risksSig™ analysis across 5,000+ companies

Get Started Free →

No credit card required

Question:
What does INTUITIVE SURGICAL INC actually do?
Answer:
Intuitive Surgical, Inc. is a global leader in robotic-assisted minimally invasive surgical care, driven by a mission to expand the potential of physicians to heal without constraints. The company provides a comprehensive ecosystem encompassing robotic-assisted surgical systems like the da Vinci platform, specialized instruments and accessories, and extensive customer learning and support services. Its offerings are designed to enhance surgeon capabilities, improve patient outcomes, and lower the total cost of care. Intuitive Surgical's products are utilized across a broad range of surgical specialties, including general, urologic, gynecologic, cardiothoracic, and head and neck surgery, as well as in diagnostic procedures with its Ion endoluminal system. The company operates globally, with a significant portion of its revenue generated in the U.S. and an increasing presence in international markets.
Question:
What are INTUITIVE SURGICAL INC's revenue drivers?
Answer:
Revenue is primarily driven by the sale of da Vinci surgical systems, instruments, and accessories, as well as service contracts and operating lease arrangements for these systems. The Ion endoluminal system and its associated instruments, accessories, and services also contribute to revenue.

Cut through noisy SEC filings to find the signal faster

Source-grounded filing intelligence with one-click links back to the filing, so you can move faster and verify everything at the source.

Get Started Free →

No credit card required